Intuitive Surgical, Inc.

“Intuitive Surgical is a structurally dominant, capital-efficient compounder with a self-reinforcing moat, pristine balance sheet, and a decade-plus reinvestment runway — but at 34.5x forward earnings and a 1.56% FCF yield, the stock fully prices in flawless execution, leaving virtually no margin of safety for new investors. The 33% drawdown from 52-week highs has improved the setup materially, but a compelling entry requires another 15–20% decline to the $295–$340 range where the risk/reward shifts decisively in the buyer's favor.”